230 related articles for article (PubMed ID: 19243632)
1. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies.
Bhaskar K; Anbu J; Ravichandiran V; Venkateswarlu V; Rao YM
Lipids Health Dis; 2009 Feb; 8():6. PubMed ID: 19243632
[TBL] [Abstract][Full Text] [Related]
2. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery.
Jain SK; Chourasia MK; Masuriha R; Soni V; Jain A; Jain NK; Gupta Y
Drug Deliv; 2005; 12(4):207-15. PubMed ID: 16036715
[TBL] [Abstract][Full Text] [Related]
4. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
5. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
[TBL] [Abstract][Full Text] [Related]
7. Formulation of Topical Flurbiprofen Solid Lipid Nanoparticle Gel Formulation Using Hot Melt Extrusion Technique.
Bagde A; Kouagou E; Singh M
AAPS PharmSciTech; 2022 Sep; 23(7):257. PubMed ID: 36114430
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.
Pathak P; Nagarsenker M
AAPS PharmSciTech; 2009; 10(3):985-92. PubMed ID: 19641997
[TBL] [Abstract][Full Text] [Related]
9. Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic-pharmacodynamic modeling approach for quantitative prediction of skin absorption.
Elkomy MH; El Menshawe SF; Eid HM; Ali AM
Drug Dev Ind Pharm; 2017 Apr; 43(4):531-544. PubMed ID: 27910712
[TBL] [Abstract][Full Text] [Related]
10. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
11. Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model.
Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Yadav R; Patel S; Verma K; Tak K
Lipids Health Dis; 2019 Jun; 18(1):133. PubMed ID: 31170970
[TBL] [Abstract][Full Text] [Related]
12. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV.
Ansari H; Singh P
Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
16. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
Silva AC; Santos D; Ferreira DC; Souto EB
Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
[TBL] [Abstract][Full Text] [Related]
17. Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application.
Dudhipala N; Ali Youssef AA; Banala N
Chem Phys Lipids; 2020 Nov; 233():104981. PubMed ID: 33031802
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
Song A; Su Z; Li S; Han F
Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972
[TBL] [Abstract][Full Text] [Related]
19. Development of galangal essential oil-based microemulsion gel for transdermal delivery of flurbiprofen: simultaneous permeability evaluation of flurbiprofen and 1,8-cineole.
Dong J; Zhu XM; Wu FY; Yang BQ; Feng H; Dong YF; Gu W; Chen J
Drug Dev Ind Pharm; 2020 Jan; 46(1):91-100. PubMed ID: 31878816
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of flurbiprofen microemulsion.
Ambade KW; Jadhav SL; Gambhire MN; Kurmi SD; Kadam VJ; Jadhav KR
Curr Drug Deliv; 2008 Jan; 5(1):32-41. PubMed ID: 18220549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
